Vect-Horus has a clinical-phase solution to a key drug development challenge: crossing the blood–brain barrier (BBB). By targeting receptors on the barrier, Vect-Horus is empowering partners such as ...
London, United Kingdom--(Newsfile Corp. - June 24, 2025) - Gorilla Technology Group Inc. (GRRR) ("Gorilla" or the "Company"), a global solution provider in Security Intelligence, Network Intelligence, ...
The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on June 5-6, 2018 to help advance discussions on the the appropriate use of devices and mobile technology to predict, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results